Genmab — September 2019

[royal]

Mon det er Jan med klokken? It is our pleasure to ring the Nasdaq Opening Bell tomorrow. A livestream of the event will be available at 9:20 AM EDT on September 10 from the Nasdaq Facebook page: facebook.com/nasdaq

[bibob]

Afsked prospectively about the future threat of Ofatumumab Roche has suggested that it has experienced minimal pushback in Ocrevus adoption due to the dosing regimen; twice yerly IV administration closely track the typical rate of patient/psysician interactions the Company says. However feedback from the 60 neurologiske ( based in the US , France , Germany and UK ) we snap- polled suggest adoption of Ocrevus would have been even faster If administered in a different way with just under a third

[Parasitism]

Sikke en dejlig åbning vi er vidne til

[bibob]

Of respondents suggesting that the sig monthly IV dose has had no impact in preventlng or delaying their use of the produkt.

[bibob]

Sig= Six

[nohope]

Når folk er syge - så har de god tid.

[polle1]

@EL & bibob : SAS tells me, they cant fly me in to NY to be there in time to meet you this afternoon

[bibob]

OK E L. I wil drink your beers.

[E_L]

OK polle, why don't you stay in charge back home then; just make sure the stock doesn't fall below 1390, ok?

[bibob]

Novartis confirmed last week that Ofatumumab has Met its primary and secondary endpoints in two phase III studies. Full data will be presented at ECTRIMS later this month and provide a much clearer indication how the efficacy of these two agents compares.

[polle1]

Wish I could, EL

[StockBull]

Støtten i 1360 er under beskydning

[bibob]

In the meantime we wanted to snap-poll MS-treating neurologists to gauge opinion towards the different dosing regimens which are use administer Ocrevus and Ofatumumab and which have been citer as a potential means of competive differentation

[StockBull]

Ser umidlbart ud til der er folk som vil supplere i 1355-1360 så måske et rebound senere på dagen op mod de 1400

[polle1]

Var det ikke meningen/forudsigelsen, at det netop skulle være je

[polle1]

her i september vi skulle peake ift alle de store kurstriggere som har været omtalt længe her ?

[Peter_Panik]

Føj for en åbning da!

[Peter_Panik]

Det var så 100 kr. ned siden toppen i sidste uge!

[bibob]

Det har vi da prøvet et utal af gange. Alt pharma får tæsk idag.

[StockBull]

Polle. Sikkert stadig sektor rotation der er igang. Både Genmab, Novo og Ørsted er banket tilbage til deres støtteområder. Har selv suppleret ligt Novo og Ørsted i håb om støtten holder. Genmab er jeg tungt lastet